Intestine Transplant Outcomes

At a Glance

• First transplant: 08/22/2010
• Transplants performed in 2023: 2
• Total number of program transplants through 2023: 49
• Received Medicare approval: 2/8/2013

Outcomes

• Median time to transplant<: 3.0 months, compared with 10.2 months nationally
• Pre-transplant mortality~: .147 (expected .097, national .097)
• Transplant rates~: 1.56 (expected 1.56, national .545

Patient survival rates for multivisceral transplant:*

• Henry Ford one-year patient survival rate: 87.50%
• Henry Ford three-year patient survival rate: 66.7%

Graft survival rate for multivisceral transplant:+

• Henry Ford one-year graft survival rate: 87.50%
• Henry Ford three-year graft survival rate: 58.03%

~ Patients on the waitlist between 01/01/2022 and 12/31/2023
*Estimated probability of surviving at one year, for patients receiving their first transplant between 01/01/2021 and 6/30/2023 and at three years, for patients receiving their first transplant between 07/01/2018 – 3/12/2020 and 6/13/2020 – 12/31/2020.
^ Adjusted for patient and donor characteristics
+ Estimated probability of surviving with a functioning graft at one year, for patients receiving their first transplant between 01/01/2021 and 6/30/2023 and at three years, for patients receiving their first transplant between 07/01/2018 – 3/12/2020 and 6/13/2020 – 12/31/2020.

Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available April 30, 2024, released July 9, 2024.

Milestones in Intestine and Multivisceral Transplantation

• First in Michigan to perform a modified multivisceral (stomach, intestinal and pancreas) transplant (2010)